Mahlon A Collins1, Jiyan An2, Danielle Peller3, Robert Bowser4. 1. Department of Neurobiology, University of Pittsburgh, 200 South Lothrop Street, Pittsburgh, PA 15213, USA; Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA. Electronic address: mac230@pitt.edu. 2. Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA. Electronic address: Jiyan.An@dignityhealth.org. 3. Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA. Electronic address: Danielle.Peller@dignityhealth.org. 4. Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA. Electronic address: Robert.Bowser@dignityhealth.org.
Abstract
BACKGROUND: Cerebrospinal fluid (CSF) has been used to identify biomarkers of neurological disease. CSF protein biomarkers identified by high-throughput methods, however, require further validation. While Western blotting (WB) is well-suited to this task, the lack of a validated loading control for CSF WB limits the method's accuracy. NEW METHOD: We investigated the use of total protein (TP) as a CSF WB loading control. Using iodine-based reversible membrane staining, we determined the linear range and consistency of the CSF TP signal. We then spiked green fluorescent protein (GFP) into CSF to create defined sample-to-sample differences in GFP levels that were measured by WB before and after TP loading correction. Levels of CSF complement C3 and cystatin C measured by WB with TP loading correction and ELISA in amyotrophic lateral sclerosis and healthy control CSF samples were then compared. RESULTS: CSF WB with the TP loading control accurately detected defined differences in GFP levels and corrected for simulated loading errors. Individual CSF sample Western blot and ELISA measurements of complement C3 and cystatin C were significantly correlated and the methods showed a comparable ability to detect between-groups differences. COMPARISON WITH EXISTING METHOD: CSF TP staining has a greater linear dynamic range and sample-to-sample consistency than albumin, a commonly used CSF loading control. The method accurately corrects for simulated errors in loading and improves the sensitivity of CSF WB compared to using no loading control. CONCLUSIONS: The TP staining loading control improves the sensitivity and accuracy of CSF WB results.
BACKGROUND: Cerebrospinal fluid (CSF) has been used to identify biomarkers of neurological disease. CSF protein biomarkers identified by high-throughput methods, however, require further validation. While Western blotting (WB) is well-suited to this task, the lack of a validated loading control for CSF WB limits the method's accuracy. NEW METHOD: We investigated the use of total protein (TP) as a CSF WB loading control. Using iodine-based reversible membrane staining, we determined the linear range and consistency of the CSF TP signal. We then spiked green fluorescent protein (GFP) into CSF to create defined sample-to-sample differences in GFP levels that were measured by WB before and after TP loading correction. Levels of CSF complement C3 and cystatin C measured by WB with TP loading correction and ELISA in amyotrophic lateral sclerosis and healthy control CSF samples were then compared. RESULTS: CSF WB with the TP loading control accurately detected defined differences in GFP levels and corrected for simulated loading errors. Individual CSF sample Western blot and ELISA measurements of complement C3 and cystatin C were significantly correlated and the methods showed a comparable ability to detect between-groups differences. COMPARISON WITH EXISTING METHOD: CSF TP staining has a greater linear dynamic range and sample-to-sample consistency than albumin, a commonly used CSF loading control. The method accurately corrects for simulated errors in loading and improves the sensitivity of CSF WB compared to using no loading control. CONCLUSIONS: The TP staining loading control improves the sensitivity and accuracy of CSF WB results.
Authors: M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui Journal: J Natl Cancer Inst Date: 2001-07-18 Impact factor: 13.506
Authors: Anja H Simonsen; Justyna M C Bahl; Pia B Danborg; Veronica Lindstrom; Severin O Larsen; Anders Grubb; Niels H H Heegaard; Gunhild Waldemar Journal: J Neurosci Methods Date: 2013-03-26 Impact factor: 2.390
Authors: Matthew Light; Kenneth H Minor; Peter DeWitt; Kyle H Jasper; Stephen J A Davies Journal: J Neuroinflammation Date: 2012-06-11 Impact factor: 8.322
Authors: Rafael Pérez-Pérez; Juan A López; Eva García-Santos; Emilio Camafeita; María Gómez-Serrano; Francisco J Ortega-Delgado; Wifredo Ricart; José M Fernández-Real; Belén Peral Journal: PLoS One Date: 2012-01-17 Impact factor: 3.240
Authors: Emanuele Persichetti; Davide Chiasserini; Lucilla Parnetti; Paolo Eusebi; Silvia Paciotti; Claudia De Carlo; Michela Codini; Nicola Tambasco; Aroldo Rossi; Omar M A El-Agnaf; Omar M El Agnaf; Paolo Calabresi; Tommaso Beccari Journal: PLoS One Date: 2014-07-01 Impact factor: 3.240
Authors: Anna S Nichenko; W Michael Southern; Kayvan Forouhesh Tehrani; Anita E Qualls; Alexandra B Flemington; Grant H Mercer; Amelia Yin; Luke J Mortensen; Hang Yin; Jarrod A Call Journal: Am J Physiol Cell Physiol Date: 2019-11-13 Impact factor: 4.249
Authors: Melyssa S Roberts; Lindsey J Anstine; Viviane S Finke; Benjamin L Bryson; Bryan M Webb; Kristen L Weber-Bonk; Darcie D Seachrist; Parth R Majmudar; Ruth A Keri Journal: Breast Cancer Res Date: 2020-06-18 Impact factor: 6.466